Mangoceuticals OverviewMangoceuticals EBIT
EBIT (Earnings Before Interest and Taxes) analysis for MGRX.
Quarterly EBIT
-$3.40M
↑ 29.88% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$16.58M
↓ 58.72% YoY
Trailing 12 months ending Mar 31, 2026
Mangoceuticals OverviewEBIT (Earnings Before Interest and Taxes) analysis for MGRX.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026